 "Torrent Pharma commissions Dahej plant")
Torrent Pharma has commenced commercial operations at its new plant in Dahej. The facility, which is the company’s fifth formulation plant and the second active pharmaceutical ingredients (APIs) plant, is being set up in a two phases. Torrent Pharma has invested over Rs 650 crore in the first phase of the plant.
The new plant, situated in Dahej SEZ is spread across 70 acres site with a built up area of around 97000 sq m. Phase I will have installed capacity of about 7,500 million tablets/capsules and 25 MT APIs per annum. The plant will cater mainly to the more regulated international markets such as US, Brazil, Germany etc.
Jinesh Shah, executive director at Torrent Pharma, said, “This plant will scale up Torrent’s manufacturing capacity to meet the growing demand from the international markets.”
With the commissioning of phase II, the construction for which is expected to commence soon, the total capacity will increase to about 14,000 million tablets/capsules and 80 MT APIs per year.
The new plant, situated in Dahej SEZ is spread across 70 acres site with a built up area of around 97000 sq m. Phase I will have installed capacity of about 7,500 million tablets/capsules and 25 MT APIs per annum. The plant will cater mainly to the more regulated international markets such as US, Brazil, Germany etc.
Jinesh Shah, executive director at Torrent Pharma, said, “This plant will scale up Torrent’s manufacturing capacity to meet the growing demand from the international markets.”
With the commissioning of phase II, the construction for which is expected to commence soon, the total capacity will increase to about 14,000 million tablets/capsules and 80 MT APIs per year.